4 Discounted TSX Stocks to Watch in June

The Canadian market remains volatile, which should spur investors to snatch up cheap TSX stocks like HEXO Corp. (TSX:HEXO)(NASDAQ:HEXO).

| More on:
value for money

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The S&P/TSX Composite Index was down 171 points in late-morning trading on May 31. Canadian stocks have enjoyed a solid rebound in the second half of May. However, impending interest rate hikes from the Bank of Canada (BoC) have conjured up investor anxieties once again. Today, I want to look at four TSX stocks that are still trading in discount territory. Are these stocks worth snatching up today? Let’s jump in.

Is this cannabis stock worth snatching up at the end of May?

HEXO (TSX:HEXO)(NASDAQ:HEXO) is a Quebec-based company that produces, markets, and sells cannabis in Canada. Its shares have dropped 65% in 2022 at the time of this writing. The stock has plunged 96% from the prior year. The cannabis sector has been reeling for months, as domestic producers continue to wade through a supply glut as well as the resurgence of the black market.

This company released its second-quarter fiscal 2022 results on March 18. Total revenues jumped 61% from the prior year to $52.8 million. Meanwhile, it nearly halved its adjusted EBITDA loss to $5.6 million. Shares of HEXO currently possess an RSI of 28. That puts this cannabis stock in technically oversold territory.

This reeling TSX stock also provides some income

Magellan Aerospace (TSX:MAL) is a Toronto-based company that designs, engineers, manufactures, and sells aero engine and structure components for the aerospace markets in Canada, the United States, Europe, and Asia. This TSX stock has plunged 25% so far this year. Its shares are down 29% from the same period in 2021.

In Q1 2022, Magellan saw revenues climb 6.5% year over year to $187 million. Meanwhile, gross profit slipped 36% to $10.9 million. The company was negatively impacted by the COVID-19 pandemic, and it predicts further uncertainty due to the ongoing war between Russia and Ukraine. Shares of this TSX stock last had an RSI of 15, which puts Magellan deep in oversold levels. It also offers a quarterly dividend of $0.08 per share, representing a solid 4.3% yield.

Here’s an equity that has recently hit a 52-week low: Is it worth buying?

Wall Financial (TSX:WFC) is a Vancouver-based real estate investment and development company. The Canadian housing market has been on fire for over a decade. However, aggressive rate tightening from policy makers threatens to curb its huge growth in the quarters ahead. Shares of this TSX stock have dropped 15% so far in 2022.

This TSX stock possesses a solid price-to-earnings (P/E) ratio of 27, which puts Wall Financial in more favourable value territory compared to its peers. Canadian real estate still has many strong fundamentals working in its favour, which is why I’m looking to buy the dip in stocks like Wall Financial.

One more struggling TSX stock to consider buying today

Andlauer (TSX:AND) is the fourth and final TSX stock I’d look to snatch up on this turbulent Tuesday. Its shares have dropped 12% so far in 2022. The stock is still up 35% from the previous year.

The company released its first-quarter 2022 results on May 4. Andlauer delivered revenue growth of 54% to $148 million. Meanwhile, EBITDA also rose 54% to $39.4 million. This healthcare stock last possessed an attractive P/E ratio of 21. It offers a quarterly dividend of $0.06 per share, which represents a modest 0.50% yield.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Andlauer Healthcare Group Inc. The Motley Fool recommends HEXO Corp.

More on Investing

Investing

KM Throwaway Post

Read more »

Investing

Carlos Test Yoast Metadata

Read more »

Investing

KM Ad Test

This is my excerpt.

Read more »

Investing

Test post for affiliate partner mockups

Updated: 9/17/2024. This post was not sponsored. The views and opinions expressed in this review are purely those of the…

Read more »

Investing

Testing Ecap Error

Premium content from Motley Fool Stock Advisor We here at Motley Fool Stock Advisor believe investors should own at least…

Read more »

Investing

TSX Today: Testing the Ad for James

la la la dee dah.

Read more »

Lady holding remote control pointed towards a TV
Investing

2 Streaming Stocks to Buy Now and 1 to Run From

There are streaming stocks on the TSX that are worth paying attention to in 2023 and beyond.

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Stocks for Beginners

Top Recession-Resilient TSX Stocks to Buy With $3,000

It's time to increase your exposure to defensives!

Read more »